Creation of The Vaccine Fund and the Global Alliance for Vaccines & Immunization at the World Economic Forum Annual Meeting in Davos, Switzerland.

Launch of the International Finance Facility for Immunisation (IFFIm), which uses long-term donor pledges to issue vaccine bonds on the capital markets.

The Advance Market Commitment (AMC) for pneumococcal vaccines is launched to incentivise manufacturers to rapidly take a new vaccine from research to development and bring it to market.

Launch of the Gavi Matching Fund which multiplies private sector partners’ impact by doubling their investment.

The name evolves from GAVI Alliance to Gavi, the Vaccine Alliance, with an updated logo that visually illustrates the global immunisation reach of the Alliance.

Hosted by the German government in Berlin, the Vaccine Alliance held a meeting to mobilise funds for global immunisation programmes through 2020.

Agreement to help push the Ebola vaccine towards regulatory approval.

Gavi moves to the Global Health Campus with the Global Fund and other partners.

Gavi receives the prestigious Lasker~Bloomberg Public Service Award for providing sustained access to childhood vaccines in the world’s poorest countries, saving millions of lives and highlighting the power of immunisation to prevent diseases.

The UK government will host Gavi’s third donor pledging conference on 3-4 June 2020 to mobilise at least an additional US$ 7.4 billion to protect the next generation with vaccines, reduce disease inequality and create a healthier, safer and more prosperous world.